| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |